Lung Non Squamous Non Small Cell Carcinoma

SEP 4, 2026 · PHASE 2 TRIAL

Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer

ClinicalTrials.gov

This is a Phase 2 trial registration with no results posted; it describes a planned interventional study testing TRC102 added to chemoradiotherapy in stage III NSCLC, designed to assess feasibility and signal before larger trials.

AUG 7, 2026 · PHASE 3 TRIAL

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

ClinicalTrials.gov

This is a Phase 3 trial registration with no results posted; the study is still recruiting and has not yet reported outcomes.